Literature DB >> 11073980

Association with Ets-1 causes ligand- and AF2-independent activation of nuclear receptors.

R M Tolón1, A I Castillo, A M Jiménez-Lara, A Aranda.   

Abstract

The vitamin D receptor (VDR) normally functions as a ligand-dependent transcriptional activator. Here we show that, in the presence of Ets-1, VDR stimulates the prolactin promoter in a ligand-independent manner, behaving as a constitutive activator. Mutations in the AF2 domain abolish vitamin D-dependent transactivation but do not affect constitutive activation by Ets-1. Therefore, in contrast with the actions of vitamin D, activation by Ets-1 is independent of the AF2 domain. Ets-1 also conferred a ligand-independent activation to the estrogen receptor and to peroxisome proliferator-activated receptor alpha. In addition, Ets-1 cooperated with the unliganded receptors to stimulate the activity of reporter constructs containing consensus response elements fused to the thymidine kinase promoter. There is a direct interaction of the receptors with Ets-1 which requires the DNA binding domains of both proteins. Interaction with Ets-1 induces a conformational change in VDR which can be detected by an increased resistance to proteolytic digestion. Furthermore, a retinoid X receptor-VDR heterodimer in which both receptors lack the core C-terminal AF2 domain can recruit coactivators in the presence, but not in the absence, of Ets-1. This suggests that Ets-1 induces a conformational change in the receptor which creates an active interaction surface with coactivators even in the AF2-defective mutants. These results demonstrate the existence of a novel mechanism, alternative to ligand binding, which can convert an unliganded receptor from an inactive state into a competent transcriptional activator.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073980      PMCID: PMC86515          DOI: 10.1128/MCB.20.23.8793-8802.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  CDK-independent activation of estrogen receptor by cyclin D1.

Authors:  R M Zwijsen; E Wientjens; R Klompmaker; J van der Sman; R Bernards; R J Michalides
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression.

Authors:  A P Bradford; C Wasylyk; B Wasylyk; A Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer.

Authors:  T Sone; S Kerner; J W Pike
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

4.  Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin gene.

Authors:  R A Maurer; A C Notides
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

5.  A transcriptional co-repressor that interacts with nuclear hormone receptors.

Authors:  J D Chen; R M Evans
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

6.  The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1.

Authors:  C L Bevan; S Hoare; F Claessens; D M Heery; M G Parker
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).

Authors:  A I Castillo; A M Jimenez-Lara; R M Tolon; A Aranda
Journal:  Mol Endocrinol       Date:  1999-07

8.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

Authors:  G Bunone; P A Briand; R J Miksicek; D Picard
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

9.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  22 in total

1.  Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells.

Authors:  Huilin Qi; Dean J Aguiar; Shelly M Williams; Alison La Pean; Wei Pan; Catherine M Verfaillie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

2.  Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells.

Authors:  Simona Caporali; Manami Imai; Lucia Altucci; Massimo Cancemi; Silvana Caristi; Luigi Cicatiello; Filomena Matarese; Roberta Penta; Dipak K Sarkar; Francesco Bresciani; Alessandro Weisz
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

3.  Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.

Authors:  Fatouma Alimirah; Avani Vaishnav; Michael McCormick; Ibtissam Echchgadda; Bandana Chatterjee; Rajendra G Mehta; Xinjian Peng
Journal:  Mol Cell Biochem       Date:  2010-05-04       Impact factor: 3.396

Review 4.  24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

Authors:  Wei Luo; Pamela A Hershberger; Donald L Trump; Candace S Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-08       Impact factor: 4.292

Review 5.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

6.  SPBP is a phosphoserine-specific repressor of estrogen receptor alpha.

Authors:  Valentina Gburcik; Nathalie Bot; Marcello Maggiolini; Didier Picard
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes.

Authors:  Ichiro Kaneko; Rimpi K Saini; Kristin P Griffin; G Kerr Whitfield; Mark R Haussler; Peter W Jurutka
Journal:  J Endocrinol       Date:  2015-07-06       Impact factor: 4.286

Review 8.  The regulatory role of miRNAs on VDR in breast cancer.

Authors:  Tatyana Singh; Brian D Adams
Journal:  Transcription       Date:  2017-06-09

9.  A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid.

Authors:  Ana I Castillo; Ruth Sánchez-Martínez; Jose L Moreno; Olaia A Martínez-Iglesias; Daniela Palacios; Ana Aranda
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 10.  Inhibitors for the Vitamin D Receptor-Coregulator Interaction.

Authors:  Kelly A Teske; Olivia Yu; Leggy A Arnold
Journal:  Vitam Horm       Date:  2015-11-30       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.